Storia in 7 fonti

Pharmalittle: We're reading about Novo suing Lilly over 'deceptive' ads, a fugitive's secret life in biotech, and more

Novo Nordisk sued Eli Lilly for allegedly running “deceptive” ads to make its obesity and diabetes drugs appear more effective

Raccontata dabiopharmadive.comstatnews.comfiercepharma.comcbsnews.comchannelnewsasia.comendpoints.newsaxios.com

Confronto fonti

6 prospettive sulla stessa storia

AI · summaries

statnews.comStai leggendo1 g fa

Pharmalittle: We're reading about Novo suing Lilly over 'deceptive' ads, a fugitive's secret life in biotech,…

Novo Nordisk sued Eli Lilly for allegedly running “deceptive” ads to make its obesity and diabetes drugs appear more effective

originale

fiercepharma.com1 g fa

Novo Nordisk files lawsuit accusing rival Eli Lilly of running ‘false and misleading’ GLP-1 ads

Novo Nordisk has accused rival Eli Lilly of runnin | Novo Nordisk has accused Eli Lilly of running ad campaigns containing “deliberately false” messages that mislead the public about the comparative efficacy of GLP-1…

Leggi questa versione → originale

biopharmadive.com1 g fa

Novo sues Lilly, alleging ‘misleading’ advertising of obesity drugs

The lawsuit follows a cease-and-desist request and argues Lilly is using “deceptive” ads to claim its GLP-1 products are broadly superior to Novo’s medicines. Lilly countered that its campaign is “truthful.”

Leggi questa versione → originale

axios.com19 h fa

Novo accuses rival Eli Lilly of "deceptive" weight-loss drug ads

The weight-loss drug wars reached a new level of intensity Tuesday as Novo Nordisk sued Eli Lilly, accusing its arch-rival of misleading advertising.

Leggi questa versione → originale

endpoints.news22 h fa

Novo sues Lilly over 'deceptive' ads comparing GLP-1 drug doses

Novo Nordisk sues Eli Lilly, alleging its Zepbound ads misleadingly compare doses against outdated Wegovy data.

Leggi questa versione → originale

channelnewsasia.com23 h fa

Pharma heavyweights Novo Nordisk and Eli Lilly clash over anti-obesity drug ads

Novo Nordisk said Eli Lilly's ads uses outdated research and leave out important information, which could mislead consumers.

Leggi questa versione → originale

Timeline cronologica

1. martedì 21 luglio 2026·biopharmadive.com
   

   Novo sues Lilly, alleging ‘misleading’ advertising of obesity drugs

   The lawsuit follows a cease-and-desist request and argues Lilly is using “deceptive” ads to claim its GLP-1 products are broadly superior to Novo’s medicines. Lilly countered that…

2. martedì 21 luglio 2026·statnews.com
   

   Pharmalittle: We're reading about Novo suing Lilly over 'deceptive' ads, a fugitive's secret life in biotech, and more

   Novo Nordisk sued Eli Lilly for allegedly running “deceptive” ads to make its obesity and diabetes drugs appear more effective

3. martedì 21 luglio 2026·fiercepharma.com
   

   Novo Nordisk files lawsuit accusing rival Eli Lilly of running ‘false and misleading’ GLP-1 ads

   Novo Nordisk has accused rival Eli Lilly of runnin | Novo Nordisk has accused Eli Lilly of running ad campaigns containing “deliberately false” messages that mislead the public…

4. martedì 21 luglio 2026·statnews.com
   

   Anthropic deepens work with rare disease drugs

   Novo Nordisk sues Eli Lilly over GLP-1s, Medicare pricing plans, and more biotech news from The Readout

5. martedì 21 luglio 2026·cbsnews.com
   

   Novo Nordisk sues Eli Lilly over "maliciously and deceptively false" GLP-1 ads

   The lawsuit alleges that Eli Lilly misled consumers by using outdated clinical trial data to make its drugs appear more effective than Novo's.

6. martedì 21 luglio 2026·channelnewsasia.com
   

   Pharma heavyweights Novo Nordisk and Eli Lilly clash over anti-obesity drug ads

   Novo Nordisk said Eli Lilly's ads uses outdated research and leave out important information, which could mislead consumers.

7. martedì 21 luglio 2026·endpoints.news
   

   Novo sues Lilly over 'deceptive' ads comparing GLP-1 drug doses

   Novo Nordisk sues Eli Lilly, alleging its Zepbound ads misleadingly compare doses against outdated Wegovy data.

8. martedì 21 luglio 2026·axios.com
   

   Novo accuses rival Eli Lilly of "deceptive" weight-loss drug ads

   The weight-loss drug wars reached a new level of intensity Tuesday as Novo Nordisk sued Eli Lilly, accusing its arch-rival of misleading advertising.